Related Experiment Video
Updated: Feb 2, 2026

Covalent Labeling with Diethylpyrocarbonate for Studying Protein Higher-Order Structure by Mass Spectrometry
Published on: June 15, 2021
Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications
Yang Jiao1, Yunpeng Feng2, Xiuli Wang3
1School of Physical Education, Northeast Normal University, Changchun, Jilin, 130024, P. R. China.
Abstract:
CDKN2A is one of the most studied tumor suppressor genes. It encodes the p16-INK4a protein that plays a critical role in the cell cycle progression, differentiation, senescence, and apoptosis. Mutations in CDKN2A or dysregulation of its functional activity are frequently associated with various types of human cancer. As a cyclin-dependent kinase inhibitor, p16-INK4a forms a complex with cyclin-dependent kinases 4/6 (CDK4/6) thereby competing with cyclin D. It is believed that the helix-turn-helix structures in the content of tandem ankyrin repeats in p16-INK4a are required for the protein interaction with CDK4. Until recently, the mechanisms considered to be involved in the regulation of p16-INK4a functions and cancer development have been mutations in DNA, homozygous or heterozygous gene loss, and methylation of CDKN2A promoter region. In this review, we discuss recent findings on the regulation of p16-INK4a by covalent modifications at both transcriptional and post-translational levels.
Insights
The CDKN2A tumor suppressor gene encodes p16-INK4a, crucial for cell cycle control. This review explores how covalent modifications regulate p16-INK4a, impacting cancer development beyond traditional genetic changes.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- CDKN2A is a critical tumor suppressor gene encoding p16-INK4a.
- p16-INK4a regulates cell cycle, differentiation, senescence, and apoptosis.
- Dysregulation of CDKN2A is linked to various human cancers.
Purpose of the Study:
- To review recent findings on p16-INK4a regulation.
- To discuss the role of covalent modifications in p16-INK4a function.
- To highlight novel regulatory mechanisms in cancer development.
Main Methods:
- Literature review of recent studies on CDKN2A.
- Analysis of transcriptional and post-translational regulation of p16-INK4a.
- Focus on covalent modifications impacting p16-INK4a activity.
Main Results:
- p16-INK4a inhibits cyclin-dependent kinases 4/6 (CDK4/6).
- Helix-turn-helix structures in ankyrin repeats are vital for CDK4 interaction.
- Beyond genetic mutations, covalent modifications represent a key regulatory layer for p16-INK4a.
Conclusions:
- Covalent modifications offer a new perspective on p16-INK4a regulation.
- Understanding these modifications is crucial for cancer therapy development.
- This review emphasizes the dynamic regulation of this key tumor suppressor.
More Related Videos
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Covalently Linked Protein Regulators
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...

